Table II.

Effect of ALA, DHA, EPA, LA, AA, GLA and 5-FU on relative gene expression of Bcl-2, Bax, and Human 18S in LoVo and RKO cells in vitro

LoVo treatment	LoVo % survival	Bcl-2 (% of CK)	Bax (% of CK)	RKO treatment	RKO % survival	Bcl-2 (% of CK)	Bax (% of CK)
Control	1.00 ±0.05A	1.00 ±0.01a	1.00 ±0.07d	Control	1 ±0.03A	1.00 ±0.02b	1.00 ±0.06c’
ALA 150 μm	0.63 ±0.01B	0.42 ±0.05c	2.20 ±0.09b’	ALA 140 μm	0.45 ±0.08B	0.52 ±0.04c	1.37 ±0.12b’
DHA 150 μm	0.63 ±0.08B	0.68 ±0.06b	1.15 ±0.11d’	DHA 120 μm	0.48 ±0.09B	1.30 ±0.14a	1.65 ±0.15b’
EPA 150 μm	0.70 ±0.05B	0.64 ±0.04b	1.22 ±0.07d’	EPA 120 μm	0.50 ±0.05B	0.70 ±0.08c	1.43 ±0.06b’
LA 150 μm	0.69 ±0.03B	0.70 ±0.02b	1.59 ±0.14c’	LA 120 μm	0.50 ±0.05B	0.65 ±0.07c	1.49 ±0.09b’
AA 150 μm	0.68 ±0.03B	0.37 ±0.02c	1.17 ±0.13d’	AA 120 μm	0.49 ±0.14B	0.72 ±0.05c	1.65 ±0.15b’
GLA 300 μm	0.63 ±0.06B	0.43 ±0.02c	1.96 ±0.19b’	GLA 200 μm	0.52 ±0.04B	0.57 ±0.09c	0.81 ±0.11c’
5-FU 10 μm	0.63 ±0.03B	0.69 ±0.06b	3.54 ±0.01a’	5-FU 0.4 μm	0.42 ±0.05B	0.74 ±0.10c	3.95 ±0.15a’

Values with different letters are significantly different (p < 0.05).